Prostamax
PROSTPeptide bioregulator studied in prostate tissue.
Also known as: Prostate peptide bioregulator
Overview
Prostamax is a short peptide bioregulator studied in prostate-tissue and urogenital-research models, part of the Khavinson bioregulator family.
A short peptide bioregulator (in the Khavinson tradition) studied for tissue-specific signaling in the prostate. The bioregulator concept proposes that very short peptides bind DNA regulatory regions to normalize gene expression in their target tissue.
Studied for modulating gene expression associated with prostate-tissue maintenance and function.
Molecular information
Part of the cytomax/cytogen short-peptide bioregulator family targeting prostate tissue.
Pharmacokinetics
Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.
Research applications
- Prostate-tissue research
- Urogenital studies
- Peptide-bioregulator investigations
Research protocols
Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.
Observed effects timeline
Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.
Course (10–20 days)
Bioregulator protocols emphasize short, repeatable courses rather than continuous use.
Between courses
Effects are proposed to persist via gene-regulatory normalization in the target tissue.
Research compatibility
Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.
Cardiogen
Distinct tissue-targeted bioregulators; often used in sequence.
Cartalax
Different target tissue; complementary in bioregulator protocols.
Testagen
Complementary reproductive/immune bioregulator.
How to reconstitute
Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Short peptides are sensitive to heat and agitation.
- 1Allow the vial to reach room temperature (15–20 minutes).
- 2Swab the stopper with alcohol and let it air dry.
- 3Add bacteriostatic water slowly down the vial wall.
- 4Swirl gently until dissolved into a clear solution.
- 5Refrigerate at 2–8 °C and protect from light.
Quality indicators
Uniform white powder
Lyophilized cake should be white to off-white without discoloration.
Clear solution
Reconstitutes to a clear, colorless, particle-free solution.
Slight clumping
Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.
Collapsed or melted appearance
Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.
Cloudy after reconstitution
Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.
Reported observations & safety
Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.
- Generally reported as well tolerated in the bioregulator literature, which is largely from a single research lineage.
- Independent replication of bioregulator claims outside the originating group is limited.
References & further reading
Short peptide bioregulators and tissue-specific gene regulation (review)
Review of the Khavinson short-peptide bioregulator concept and proposed tissue-specific gene-regulatory activity.
View studyTopics
This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.
Sparse published data; largely preliminary or anecdotal.
This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.
Browse catalogue